About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Readmission Following Prostatic Surgery | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06101576

Readmission Following Prostatic Surgery

This study will be conducted to estimate readmission rate and reasons for readmission after all modalities of endoscopic transurethral surgeries for treatment of BOO secondary to BPH in the last 20 ye...

Lead sponsor: Mansoura University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Ahmed R EL-Nahas, MD

CONTACT

+201221136899 ar_el_nahas@yahoo.com

Amr W Yehia, MD

CONTACT

+201027383536 amrwaei33@yahoo.com

Sponsors

Lead Sponsor

Mansoura University

Computerized patient information system (PIS) of Urology and Nephrology Center (UNC) and database of prostate unit of UNC will be reviewed for all preoperative, intraoperative and post discharge data. All follow up visits will be traced for outcome measurement. Patients with no hospital follow up visit will be contacted by phone and interrogated about their LUTS control state, ongoing medication and history of secondary procedures.

Age

40 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Men who underwent transurethral prostatic surgery for BPH causing BOO at Urology and Nephrology Center, Mansoura University, Egypt from Jun. 2005 to Dec. 2024.

Exclusion Criteria

•1. Patients who underwent TUR tunnelling for prostatic adenocarcinoma.
•2. LUTS secondary to neuropathic bladder.
•3. Incidentally diagnosed prostate cancer after surgery

Related studies

Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

NCT07187180 · BPH With Symptomatic Lower Urinary Tract Symptoms, BPH With Urinary Obstruction

RECRUITINGPhase 3

Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP

NCT05620784 · BPH With Urinary Obstruction, BPH, and more

Active Not RecruitingNA

WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia

NCT04801381 · BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Not Yet RecruitingPhase 3

Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation Surgery

NCT07209150 · BPH With Urinary Obstruction, Antibiotic Prophylaxis

Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL)

NCT03605745 · BPH With Urinary Obstruction, BPH, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 26, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment4,000

Start dateJan 2005

Last updatedOct 26, 2023

Condition

BPH With Urinary Obstruction

Locations shown

Urology and Nephrology Center

Al Mansurah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 26, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions